Recombinant Human MAGEA6 protein (His tag C-Terminus)
Be the first to review this product! 리뷰 제출
|
(1 출판물)
Recombinant Human MAGEA6 protein (His tag C-Terminus) is a Human Full Length protein, in the 1 to 314 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE, Mass Spec.
대체 명칭 보기
MAGE6, MAGEA6, Melanoma-associated antigen 6, Cancer/testis antigen 1.6, MAGE-6 antigen, MAGE3B antigen, CT1.6
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human MAGEA6 protein (His tag C-Terminus) (AB126656)
15% SDS-PAGE showing ab126656 (3µg).
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MAGEA6 is involved in cellular processes relating to gene regulation and apoptosis. It interacts with other MAGE proteins and is often part of a larger multiprotein complex which influences gene transcription. The protein plays a role in cell survival and proliferation particularly in tumorous cells where it can aid in escape from immune surveillance.
Pathways
MAGEA6 participates in critical signaling pathways including the p53 pathway. This pathway is significant in regulating cell cycle arrest DNA repair and apoptosis. MAGEA6 can interact with proteins like p53 and MDM2 potentially modulating the tumor suppressor functions of p53. This interaction highlights its role in tumor pathogenesis as it can affect cell cycle regulation and apoptosis resistance.
일반 정보
기능
Activator of ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases that acts as a repressor of autophagy (PubMed : 17942928, PubMed : 20864041, PubMed : 31267705). May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3 : substrate complex (PubMed : 17942928, PubMed : 20864041). May play a role in tumor transformation or aspects of tumor progression (PubMed : 17942928, PubMed : 20864041). In vitro promotes cell viability in melanoma cell lines (PubMed : 17942928).
Post-translational modifications
Ubiquitinated by the DCX(DCAF12) complex specifically recognizes the diglutamate (Glu-Glu) at the C-terminus, leading to its degradation.
타겟 정보
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Cancers 16: PubMed39409926
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com